Sign Up to like & get
recommendations!
1
Published in 2017 at "Haematologica"
DOI: 10.3324/haematol.2016.160408
Abstract: Over the past decade, the survival of patients with multiple myeloma (MM) has dramatically improved. This remarkable change is largely due to an increase in the anti-myeloma armamentarium, including next generation proteasome inhibitors (carfilzomib, ixazomib),…
read more here.
Keywords:
sustained response;
venetoclax therapy;
myeloma;
response venetoclax ... See more keywords